About Comparative Biosciences, Inc.
Comparative Biosciences was founded in 1996 to provide expert scientific resources and quality service to all sectors of the biomedical and biopharmaceutical community. They offer extensive experience in GLP and non-GLP preclinical toxicology, efficacy, pharmacology, pharmacokinetics-pharmacodynamics, histopathology and safety studies on all laboratory species.
There particular areas of expertise include ocular, dermatology, fibrosis, otic/ototoxicity, wound healing, burns, stem cells, oncology, renal, ophthalmology, inflammation, immune-mediated models, cardiovascular and pulmonary studies, and infection models and devices, as well as contract histopathology, immunohistochemistry and custom model development.
They have a fully staffed, state-of-the-art, AAALAC-accredited facility that is purpose-built with both an in-house histopathology laboratory and a full-time quality assurance unit. They are registered with the FDA, USDA and OLAW, and our clients range from small biomedical companies to pharmaceutical giants, academia, defense and government.
WHAT WE DO FOR COMPARATIVE BIOSCIENCES MARKETING:
Rollinson provides the best resources and quality marketing service to all sectors of the biomedical community. With a multitude of expertise, we are able to serve pharmaceutical and other biotech companies as well as academic, industrial and governmental organizations. Our extensive experience performing marketing research in GLP and non-GLP preclinical toxicology, efficacy, pharmacology, pharmacokinetics-pharmacodynamics, histopathology, and safety studies make us the ideal collaborator for all scientific marketing.
